#Elastomeric Infusion Pumps Market share

[kirancmi]

Elastomeric Infusion Pumps Market Poised To Grow At A Robust Pace Owing To Rising Demand For Ambulatory Infusion Services

Elastomeric infusion pumps, also known as balloon pumps, are medical devices used to deliver controlled volumes of medicines, nutrients or other fluids into a patient's body in a precise, continuous manner. They utilize elastic balloons made of medical-grade silicone to administer the prescribed medication dose over time, automatically stopping when fluid delivery is complete. Elastomeric pump technology offers numerous advantages including portability, silent operation and high medication accuracy. The pumps are ideal for chronic therapies, pain management and chemotherapy regimens that need to be dispersed over a period of time. Commonly used for labor and delivery management, neonatology, pediatric intravenous therapy and chronic conditions like cancer and diabetes, these disposable pumps provide ambulatory infusion services and enable enhanced patient mobility and comfort compared to traditional infusion systems. The global elastomeric infusion pumps market is estimated to be valued at US$ 446.31 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key drivers for the growth of elastomeric infusion pumps market is the rising demand for ambulatory infusion services. Ambulatory infusion refers to administration of medications outside of a hospital setting and traditionally covered only a limited number of conditions. However, with technological advancements that have made elastomeric pumps smaller, lighter and more accurate, their use has expanded tremendously. Patients now have access to a wide range of critical therapies like chemotherapy, antibiotic administration, pain management and total parenteral nutrition outside the hospital setting. This significantly improves health outcomes and quality of life while lowering costs for payers. Advances in pump accessories like improved volume accuracy, safety features and connectivity with healthcare providers has led to wider acceptance of ambulatory infusion. SWOT Analysis Strength: Elastomeric infusion pumps have several advantages over traditional pumps. They are durable, portable and require less maintenance. Most elastomeric pumps are pre-filled and ready to use which avoids the hassle of tubing connections. Patients can lead active lives with these small and lightweight pumps. Weakness: Elastomeric pumps have less precision than electronic pumps which may impact highly sensitive patients and drug therapies. The flow rate cannot be adjusted once set. There is also a risk of medication underdosing or overdosing if the pump malfunctions or becomes blocked. Opportunity: With the rising prevalence of chronic diseases requiring long-term drug therapies, the demand for ambulatory infusion pumps is growing. Elastomeric pumps are well-suited for patients requiring intermittent or continuous drug delivery at home or while traveling. New product developments focusing on enhanced accuracy and reliability will expand the market potential. Threats: Stiff competition from electronic infusion pumps poses a major threat. Technological advancements are making electronic pumps more portable and affordable. Stringent regulatory approvals also increase entry barriers for new players in this market. Key Takeaways The global elastomeric infusion pumps market size is expected to witness high growth over the forecast period from 2024 to 2031. The global Elastomeric Infusion Pumps Market is estimated to be valued at US$ 446.31 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031.

Regional analysis

shows that North America currently dominates the market attributed to the rising geriatric population and chronic diseases such as cancer requiring long-term drug infusion. However, Asia Pacific is likely to grow at the fastest pace due to growing medical infrastructure and increasing healthcare spending in China and India. Key players

operating in the elastomeric infusion pumps market are Sika AG, BASF SE, Fosroc International Limited, Saint-Gobain Weber, The Euclid Chemical Company, Dayton Superior Corporation, WR Meadows, Specified Technologies Inc, TCC Materials and EMSEAL Joint Systems Ltd. The market landscape remains competitive with these companies focusing on new product launches, collaborations and mergers and acquisitions to gain market share. For instance, Sika AG acquired King Packers in 2021 to expand its concrete admixture and repair portfolio.

Get more insights on this topic: https://www.newsstatix.com/elastomeric-infusion-pumps-market-industry-insights-trends-elastomeric-infusion-pumps-market/

[credenceresearchdotblog]

The balloon infuser market size stood at approximately $2,208.00 million USD, marking a pivotal point in its evolution. This figure, while substantial, merely hinted at the market’s potential for expansion. By 2032, the balloon infuser market had surged to an impressive $4,348.00 million USD, reflecting a compound annual growth rate (CAGR) of 6.66 percent. The balloon infusers market, a niche yet rapidly expanding segment of the medical devices industry, is witnessing significant growth driven by technological advancements, increasing prevalence of chronic diseases, and a growing emphasis on patient-centric healthcare solutions. Balloon infusers, also known as elastomeric infusion pumps, are compact, portable devices that deliver controlled amounts of medication, such as pain relief drugs, antibiotics, and chemotherapy agents, over a set period. This article delves into the current trends, market dynamics, key players, and future prospects of the balloon infusers market.

Browse the full report at https://www.credenceresearch.com/report/balloon-infusers-market

Market Overview

Balloon infusers are particularly popular in home healthcare settings due to their simplicity, reliability, and ease of use. These devices have become essential in outpatient care, enabling patients to receive continuous medication without the need for hospital stays. The growing preference for home-based treatments, spurred by the COVID-19 pandemic, has further fueled the demand for balloon infusers.

Key Market Drivers

1. Technological Advancements: Innovations in balloon infuser design and materials have significantly improved the accuracy and safety of these devices. Enhanced elastomeric materials offer better control over drug delivery rates, minimizing the risk of dosage errors and improving patient outcomes.

2. Rising Prevalence of Chronic Disease: The increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions necessitates long-term medication management. Balloon infusers provide a convenient solution for the continuous delivery of drugs, improving patient compliance and quality of life.

3. Shift Towards Home Healthcare: The healthcare industry is witnessing a paradigm shift towards home-based care, driven by the need to reduce hospital costs and the desire to enhance patient comfort. Balloon infusers support this trend by enabling patients to receive necessary treatments in the comfort of their homes.

4. Increasing Surgical Procedures: The rising number of surgical procedures globally has increased the demand for post-operative pain management solutions. Balloon infusers are widely used for administering local anesthetics and analgesics, ensuring effective pain control and faster recovery.

Market Challenges

Despite the promising growth prospects, the balloon infusers market faces several challenges:

1. Stringent Regulatory Requirements: The development and commercialization of medical devices are subject to rigorous regulatory scrutiny. Manufacturers must adhere to stringent quality standards and obtain necessary approvals, which can be time-consuming and costly.

2. High Costs: The initial cost of balloon infusers can be a barrier for some patients and healthcare providers. However, the long-term benefits and reduced hospital stay costs often offset this initial investment.

3. Limited Awareness: In certain regions, there is a lack of awareness among patients and healthcare professionals about the benefits and availability of balloon infusers. Educational initiatives and targeted marketing efforts are essential to overcome this hurdle.

Key Players and Competitive Landscape

The balloon infusers market is highly competitive, with several key players striving to enhance their market share through product innovation, strategic partnerships, and mergers and acquisitions. Some of the prominent companies in this market include:

- Baxter International Inc.: A global leader in healthcare products, Baxter offers a wide range of elastomeric infusion pumps known for their reliability and precision. - Fresenius Kabi AG: This German healthcare company provides innovative balloon infusers designed for various therapeutic applications, emphasizing patient safety and comfort. - B. Braun Melsungen AG: B. Braun's portfolio includes advanced elastomeric infusion devices that cater to diverse medical needs, backed by robust research and development capabilities. - Avanos Medical, Inc.: Specializing in pain management and chronic care, Avanos offers balloon infusers that are easy to use and ensure consistent drug delivery.

Future Prospects

The future of the balloon infusers market looks promising, with several trends shaping its trajectory:

1. Personalized Medicine: Advances in biotechnology and genomics are paving the way for personalized medicine, where treatments are tailored to individual patient needs. Balloon infusers can play a crucial role in this paradigm by providing customized drug delivery solutions.

2. Expansion in Emerging Markets: As healthcare infrastructure improves in emerging markets, the demand for advanced medical devices, including balloon infusers, is expected to rise. Companies are increasingly focusing on these regions to tap into the growing opportunities.

3. Integration with Digital Health: The integration of balloon infusers with digital health technologies, such as remote monitoring and telemedicine, can enhance patient care and compliance. These connected devices can provide real-time data to healthcare providers, enabling timely interventions and personalized treatment adjustments.

Key Players

Smiths Medical

Avanos Medical, Inc.

Ambu A/S

Halomedical Systems Ltd.

Pfm Medical Ag

Daiken Medical Co., Ltd.

Palex Medical SA

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter International Inc.

Terumo Corporation

Nipro Corporation

Canack Technology Ltd.

PROMECON GmbH.

Segments

By Product:

Continuous-Rate Elastomeric Pumps

Variable-Rate Elastomeric Pumps

By Application:

Pain Management

Antibiotic Therapy

Antiviral Therapy

Chemotherapy

Others

By End User:

Hospitals

Ambulatory Surgical Centers

Home Care Settings

Speciality Clinics

Others

By Region:

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Rest of the World

Middle East

Africa

Latin America

Browse the full report at https://www.credenceresearch.com/report/balloon-infusers-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[desaletushki]

Global Home Infusion Therapy Market Size, Share And Trends Analysis Report 2030

The global home infusion therapy market size is expected to reach USD 61.7 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2023 to 2030. Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Home Infusion Therapy Market Report Highlights

By product, infusion pump emerged as the largest segment in 2022 owing to the increasing use of delivery fluids such as nutrients and medications

The anti-infective application segment dominated the market in 2022 as a large number of procedures are performed during the administration of medications, such as antibiotics and antifungals

North America dominated the global market in 2022 owing to the increasing demand for new technologies, along with advanced healthcare infrastructure

The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

Home Infusion Therapy Market Segmentation

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Product Outlook (Revenue, USD Million, 2017 - 2030)

Infusion Pumps

Elastomeric Pumps

Electromechanical

Gravity

Others

Intravenous Sets

IV Cannulas

Needleless Connectors

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2017 - 2030)

Anti-infective

Endocrinology

Diabetes

Others

Hydration Therapy

Athletes

Others

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Others

Home Infusion Therapy Route of Administration Outlook (Revenue, USD Million, 2017 - 2030)

Intramuscular

Subcutaneously

Epidural

Regional Insights

North America dominated the market in 2022 with a revenue share of over 56.5% and this trend is expected to continue throughout the forecast period. This can be attributed to the increasing R&D in the region and the rising adoption of new technology in infusion pumps. The increasing need for long-term therapy for patients with certain conditions is driving the regional market. Development of alternate healthcare settings and home infusion services and shifting preference from acute care to home care settings due to the low cost and enhanced patient mobility would boost the growth of this market in the coming years.

The Asia Pacific market is expected to register the fastest CAGR of 9.9% over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region. The growing geriatric population and the rise in chronic diseases in the region are expected to further fuel the market growth. According to the Times of India, around 75 million people over the age of 60 years suffer from some chronic disease in India, which might increase the adoption of home care services in the country.

List of Key Players of Home Infusion Therapy Market

CVS/Coram

Option Care Health

CareFusion Corporation

BriovaRx/Diplomat (UnitedHealth Optum)

PharMerica

Fresenius Kabi

ICU Medical, Inc.

Braun Melsungen AG

Baxter

BD

Caesarea Medical Electronics

Smiths Medical

Terumo Corporation

JMS Co. Ltd.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

[anitahorne]

Chemotherapy Infusion Pumps Market 2020| Report Highlights the Competitive Scenario with Impact of Drivers and Challenges 2026

Global Chemotherapy Infusion Pumps Market reports provide in-depth analysis of Top Players, Geography, End users, Applications, Competitor analysis, SWOT Analysis, Revenue, Price, Gross Margin, Market Share, Import-Export data, Trends and Forecast 2026.

Global Chemotherapy Infusion Pumps Market in-depth insights which includes the competitiveness of the trending players. this market report provides a basic overview of the industry including definitions, classifications, applications and chain structure. Analysts have carefully evaluated the milestones achieved by the Chemotherapy Infusion Pumps Market and the current trends that are likely to shape its future. Primary and secondary research methodologies have been used to put together an exhaustive report on the subject.

Leading players covered in the Chemotherapy Infusion Pumps market report: Becton, Dickinson, ICU Medical, Terumo Corporation, B. Braun, Halyard Health, Smiths Group, Baxter International, Fresenius, Moog, Zyno Medical, Micrel Medical and More...

Get Free sample copy of this report before purchase@: https://www.marketinforeports.com/report/request-sample/2721

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into: LVP (Large Volume Pump) Syringe Pump Elastomeric Pumps

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into: Hospital & Clinic Home Care

Regional Chemotherapy Infusion Pumps Market (Regional Output, Demand & Forecast by Countries):

North America (United States, Canada, Mexico) South America (Brazil, Argentina, Ecuador, Chile) Asia Pacific (China, Japan, India, Korea) Europe (Germany, UK, France, Italy) Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.

The latest report added by Market Info Reports demonstrates that the global Chemotherapy Infusion Pumps market will showcase a steady CAGR in the coming years. The research report includes a thorough analysis of market drivers, restraints, threats, and opportunities. It addresses the lucrative investment options for the players in the coming years. Analysts have offered market estimates at a global and regional level.

Major Points Covered in TOC:

Overview: Along with a broad overview of the global Chemotherapy Infusion Pumps market, this section gives an overview of the report to give an idea about the nature and contents of the research study.

Analysis on Strategies of Leading Players: Market players can use this analysis to gain competitive advantage over their competitors in the Chemotherapy Infusion Pumps market.

Study on Key Market Trends: This section of the report offers deeper analysis of latest and future trends of the Chemotherapy Infusion Pumps market.

Market Forecasts: Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. The report also provides consumption, production, sales, and other forecasts for the Chemotherapy Infusion Pumps market.

Regional Growth Analysis: All major regions and countries have been covered in the report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets.

Segmental Analysis: The report provides accurate and reliable forecasts of the market share of important segments of the Chemotherapy Infusion Pumps market. Market participants can use this analysis to make strategic investments in key growth pockets of the Chemotherapy Infusion Pumps market.

For More Information: https://www.marketinforeports.com/report/details/2721/global-chemotherapy-infusion-pumps-market

The following report covers important features such as:

Chemotherapy Infusion Pumps market dynamics

Market segmentation

Historical, contemporary, and protruding market size in terms of value, volume, and revenue

Industry trends and developments

Competitive landscape

Strategies and product portfolio

Potential and niche segments

Regions exhibiting lucrative opportunities

Customization of the Report:

Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the Report@: https://www.marketinforeports.com/report/request-customization/2721/global-chemotherapy-infusion-pumps-market

Contact Us: Mr. Marcus Kel Call: +1 415 658 9988 (International) +91 84 839 65921 (IND) Email: sales@marketinforeports.com

[vicky8588]

Infusion Systems Market

Market Overview

The Global Infusion Systems market is growing at a steady pace and is expected to exhibit a CAGR of about 5% from 2021 to 2028.

 The primary market driver for the global infusion systems market includes the rising prevalence of chronic diseases such as cancer and diabetes and significant technological advancements.

 Infusion Systems is a device used to deliver fluids into a patient’s body in a controlled manner. They may be used to provide nutrients or medications – such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.

 However, factors concerning patient safety and improper infusion leading to severe consequences will hamper the growth of the market.

Download Free Samples @ https://www.datamintelligence.com/download-sample/infusion-systems-market

 Market Segmentation

The Global Infusion Systems market report segments the market by product type, by application, by end-user, and by region.

 Based on product type, the market is segmented into volumetric infusion systems; patient-controlled analgesia pump, disposable infusion system, syringe infusion system, ambulatory infusion system, and implantable infusion system.

 The volumetric infusion system is sub-segmented into Large volume and Small volume pumps.

 By end-user, the market is segmented into the hospital, diagnostic centers, specialty oncology wards, and home care settings. Infusion systems are extensively used in hospitals and home care settings to provide improved care to patients.

 Hospitals are the largest end-users of infusion systems and account for over half of the market share.

 Market Regional Share

Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW. In 2017, the market was dominated by North America owing to favorable reimbursement and government regulations towards the infusion systems. Asia-Pacific will be the fastest-growing market due to increasing patient awareness and greater healthcare expenditure.

 The report also profiles the following companies in the Infusion Systems market ��� Smiths Medical, Terumo Medical Corporation, NIPRO Medical Corporation, Zyno Medical, B. Braun, Baxter International, Fresenius, IRADIMED CORPORATION, Hospira, and so on.

View Full Report @ https://www.datamintelligence.com/research-report/infusion-systems-market

 Market Analysis

By Product Type

 Elastomeric infusion system

Volumetric infusion system

 Patient Controlled Analgesia pump

 Disposable infusion system

 Syringe infusion system

 Ambulatory infusion system

 Implantable infusion system

 By Application

 Chemotherapy

 Diabetes

 Pain management

 Gastrointestinal Disorders

 Clinical nutrition

 Pediatrics

 By End-Users

 Hospitals

 Diagnostic Centres

 Specialty Oncology Wards

 Home care

 By Region

 Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

 Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

 North America (The USA, Canada, Mexico)

 South America (Brazil, Argentina, Rest of South America)

 Rest of the World

For Enquiry @ https://www.datamintelligence.com/enquiry/infusion-systems-market

 About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

 For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website: www.datamintelligence.com

[alex121world]

Home Infusion Therapy Devices Market size Flourish at size 2028

Infusion therapy entails management of medicine through a catheter or needle. Home infusion therapy is utilized for the handling of these diseases for example diabetes, gastrointestinal diseases, cancer, acute infections cystic fibrosis and dehydration. It is permitted by physicians as well as managed by nurses and trained professionals. This therapy is utilized when the oral medication is not functional for curing of diseases.

The worldwide home infusion therapy devices market is projected to reach a market value of about US$ XX Billion by the end of the year 2018 and registering a XX% CAGR forecasted period by 2028. The growth of the overall market is mainly fuelled by rising diabetes and cancer, rising occurrences of pain, surging geriatric population, encouraging settlements for home infusion therapy in addition to increasing awareness towards the use of these devices.

However, reported errors and immeasurable product recalls, lack of trained professionals and standard usage guidelines and lack of appropriate diagnosis/treatment alternatives for the ailments are some aspects that are likely to impede the overall growth of the home infusion therapy devices market in the coming years.

Market Segmentation

On the basis of product type, the market is segmented into infusion system pumps accessories, insulin pumps, disposable elastomeric pumps and electronic ambulatory pumps and PCA pumps. Disposable elastomeric pumps will be accounting for the biggest market share by dominating the overall market and exhibiting a robust CAGR during the eight-year forecast period.

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/3380

On the basis of application, the market is categorized into chemotherapy, parenteral nutrition, antibiotic administration enteral nutrition, chemotherapy, parenteral nutrition, antibiotic administration, enteral nutrition and others. The parenteral nutrition is considered to be dominating over the anticipated period along with recording a robust CAGR among other segments.

The end user market has been segmented into two broad categories long-term care centers and home care setting. The home care setting will be the most lucrative during the forecasted period, in addition, will be recording the highest CAGR in comparison to long-term care centers.

The regions are segmented on the basis of Latin America, North America, Europe, APAC and MEA. North America is likely to lead the overall market in addition to expanding at a XX% CAGR through the assessment period. However, APAC will be the fastest growing region among others in terms of revenue in the overall market by exhibiting a CAGR of XX% during the assessment period.

Key Market Players

The prominent players operating in the overall market includes • Baxter International Inc. • Johnson & Johnson Private Limited (Animas Corporation) • Becton, Dickinson and Company • B. Braun Melsungen AG. • Pfizer Inc. • Terumo Corporation • Fresenius Kabi AG • Smith & Nephew • F. Hoffmann-La Roche AG • Micrel Medical Devices S.A.

[marketresearchindia]

Global Chemotherapy Devices Market 2021 Global Industry Trends, Market Growth, Top Key Players and Future Prospects 2027: Ken Research

Buy Now

The global Chemotherapy Devices market was valued at 172.99 Million USD in 2020 and will grow with a CAGR of 5.5% from 2020 to 2027, based on HNY Research newly published report.

The prime objective of this report” Global and Regional Chemotherapy Devices Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027” is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Chemotherapy pumps are one of the ways patients can have their chemotherapy. It allows patients to have chemo in a controlled way. Chemotherapy pumps are also called infusion pumps. Chemotherapy pumps may be capable of delivering fluids in large or small amounts, and may be used to deliver chemotherapy drugs.The classification of Chemotherapy Devices includes LVP, Syringe Pump and Elastomeric Pumps. The proportion of Syringe Pump in 2016 is about 36.4%, and the proportion is in decreasing trend from 2012 to 2016. North America is the largest consumption market of Chemotherapy Devices, with a sales market share nearly 38.6% in 2016. Europe is the second largest consumption market of Chemotherapy Devices, enjoying market share nearly 37.1% in 2016. Market competition is high. Becton, Dickinson, ICU Medical, Terumo Corporation, B. Braun, Halyard Health, Smiths Group, Baxter International and Fresenius are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Request For Sample Report: https://kenresearch.com/sample-report.php?Frmdetails=NDcwNjk4

By Market Verdors:

Becton, Dickinson

ICU Medical

Terumo Corporation

Braun

Halyard Health

Smiths Group

Baxter International

Fresenius

Moog

Zyno Medical

Micrel Medical

By Types:

LVP (Large Volume Pump)

Syringe Pump

Elastomeric Pumps

By Applications:

Hospital & Clinic

Home Care

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

For More Information, refer to below link:-

Global and Regional Chemotherapy Devices Market Research Report

Related Reports

Global and Regional Cardiovascular Monitoring and Diagnostic Devices Industry Status and Prospects Professional Market Research Report Standard Version 2021-2027

2021-2027 Global and Regional Medical Non-woven Disposables Industry Status and Prospects Professional Market Research Report Standard Version

Contact Us:-

Ken Research                                                                      

Ankur Gupta, Head Marketing & Communications

support@kenresearch.com

[credenceresearchdotblog]

The Elastomeric Infusion Pump market is projected to witness substantial growth, with its value expected to surge from USD 1,241 million in 2023 to USD 2,646 million by 2032, reflecting a remarkable compound annual growth rate of 8.14%.The Intravenous (IV) Tubing Sets and Accessories market is an integral component of the broader healthcare landscape. These products are essential for the administration of fluids, medications, and nutrients directly into a patient’s vein, providing vital support in various medical treatments. The market for IV tubing sets and accessories has been experiencing substantial growth, driven by increasing healthcare demands, technological advancements, and a rising prevalence of chronic diseases. This article delves into the key aspects of this market, exploring its current state, growth drivers, and future prospects.

Browse the full report at https://www.credenceresearch.com/report/elastomeric-infusion-pumps-market

Market Overview

The IV tubing sets and accessories market encompasses a wide range of products, including primary IV sets, secondary IV sets, extension sets, IV catheters, needleless connectors, and more. These products are used in hospitals, clinics, ambulatory surgical centers, and home healthcare settings. The market is characterized by a high degree of innovation, with manufacturers continually developing new and improved products to enhance patient safety and comfort.

Growth Drivers

1. Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is a significant driver of the IV tubing sets and accessories market. These conditions often require long-term treatment and frequent administration of medications via IV, boosting the demand for IV sets and accessories.

2. Aging Population: The global population is aging, leading to a higher prevalence of age-related health issues. Older adults are more likely to require medical interventions that involve IV therapy, further propelling market growth.

3. Technological Advancements: Continuous advancements in IV technology have led to the development of more efficient and safer products. Innovations such as closed system transfer devices (CSTDs), which reduce the risk of contamination and improve safety, are gaining traction in the market.

4. Expansion of Home Healthcare: The trend towards home healthcare is growing, driven by the need for cost-effective treatment options and patient preference for receiving care in a familiar environment. This shift has increased the demand for user-friendly IV tubing sets and accessories that can be safely used outside of traditional healthcare settings.

5. Increased Healthcare Spending: Governments and private sectors are investing heavily in healthcare infrastructure, particularly in emerging economies. This investment is facilitating the expansion of healthcare facilities and services, thereby driving the demand for IV tubing sets and accessories.

Market Challenges

Despite the promising growth prospects, the IV tubing sets and accessories market faces several challenges. These include stringent regulatory requirements, the high cost of advanced products, and the risk of infections associated with IV therapy. Manufacturers must navigate these challenges while ensuring compliance with safety standards and maintaining affordability.

Regional Insights

The IV tubing sets and accessories market exhibits regional variations, with North America, Europe, Asia-Pacific, and Latin America being the key regions.

- North America: This region holds a significant share of the market, driven by advanced healthcare infrastructure, high healthcare spending, and a large patient population with chronic diseases. - Europe: Europe is another major market, with countries like Germany, France, and the UK contributing substantially. The presence of established healthcare systems and a focus on patient safety are key factors driving growth in this region.

- Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth, attributed to improving healthcare infrastructure, increasing healthcare expenditure, and a large population base. Countries like China and India are at the forefront of this growth.

- Latin America: This region is also showing potential for market expansion, driven by increasing awareness about healthcare and improving medical facilities.

Future Prospects

The future of the IV tubing sets and accessories market looks promising, with several trends poised to shape its trajectory. The growing focus on patient safety and infection control is likely to drive the adoption of advanced IV products. Moreover, the increasing emphasis on minimally invasive procedures and the rising trend of home healthcare will continue to boost market growth.

Key Players

Baxter International

Braun Melsungen AG

Nipro Corporation

Leventon, S.A.U

Avanos Medical, Inc

Segments:

By Product Type:

Continuous Rate Elastomeric Pump

Variable Rate Elastomeric Infusion Pump

By Application

Pain Management

Chemotherapy

Chelation Therapy

Others

By End-User

Hospitals

Ambulatory Surgical Centers

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[chitrakullkarni]

Home Infusion Therapy Market Global Demand, Application Outlook and Research Report

The global Home Infusion Therapy Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities.

Key Players:

Braun Melsungen AG

Baxter

Caesarea Medical Electronics

CareFusion Corporation

Fresenius Kabi

ICU Medical Inc.

JMS Co. Ltd.

Smiths Medical

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market/request-sample

Growth Drivers:

Driving factors for home infusion therapy market include rise in geriatric population and availability of medical attention under a strong infrastructure. Apart, homecare therapies/home infusion therapies are gaining a significant traction in the low income regions since medical needs are unavailable during emergencies. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. However, expensive nature of home infusion therapy might challenge the market demand. Product segment for home infusion therapy market includes infusion pump sets, IV cannulas and needleless connectors. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.

Product Outlook:

Infusion pumpsAmbulatory infusion pumps Insulin pumps Syringe pumps Elastomeric pumps Patient Controlled Analgesics (PCA)

Intravenous Sets

IV Cannulas

Needleless Connectors

Application Outlook:

Anti-Infectives

EndocrinologyDiabetes

Hydration TherapyAthletes

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Regional Outlook:

Geographical segmentation for home infusion therapy market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share in the forecast period due to rise in government support and advances in medical technology. Medical benefits offered by government in these regions are likely to trigger the market growth.

Asia-Pacific regions are likely to grow at a significant share in the global market due to presence of medical infrastructure and rise in patient awareness. The homecare therapies are gaining traction due to emphasis on patient betterment and proper medical attention for geriatric patients. The key players in the home infusion therapy industry include Baxter, B.Braun Melsungen AG, Caesarea Medical Electronics, ICU Medical Inc, Care Fusion Corporation, Fresenius Kabi AG, Terumo Corporation, Smiths Medicala and JMS Co Ltd.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

[daisyri-me]

Home Infusion Therapy Market : Current Trends and Market Challenges by 2024

The global Home Infusion Therapy Market is anticipated to grow at a significant CAGR during the forecast period. Home infusion therapy is an integral part of professional practice in developed countries. Though the patients’ scenarios are different under various circumstances, a considerable amount of risk is always involved. The nature of home infusion therapy is not only limited to patient care and device, but also it actively involves accumulation of consumables and enactment of quality improvement and research activities.

Free Exclusive Sample of this Report @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market/request-sample

Driving factors for home infusion therapy market include rise in geriatric population and availability of medical attention under a strong infrastructure. Apart, homecare therapies/home infusion therapies are gaining a significant traction in the low income regions since medical needs are unavailable during emergencies. Medical practices inclined towards patient betterment are expected to gain a huge traction in the forecast period. However, expensive nature of home infusion therapy might challenge the market demand. Product segment for home infusion therapy market includes infusion pump sets, IV cannulas and needleless connectors. Application segment includes endocrinology, parenteral nutrition, and hydration therapy.

Geographical segmentation for home infusion therapy market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share in the forecast period due to rise in government support and advances in medical technology. Medical benefits offered by government in these regions are likely to trigger the market growth.

Asia-Pacific regions are likely to grow at a significant share in the global market due to presence of medical infrastructure and rise in patient awareness. The homecare therapies are gaining traction due to emphasis on patient betterment and proper medical attention for geriatric patients. The key players in the home infusion therapy industry include Baxter, B.Braun Melsungen AG, Caesarea Medical Electronics, ICU Medical Inc, Care Fusion Corporation, Fresenius Kabi AG, Terumo Corporation, Smiths Medicala and JMS Co Ltd.

Browse Full Report With TOC @ https://www.millioninsights.com/industry-reports/home-infusion-therapy-market

Market Segment:

Product Outlook (Market revenue in USD Million, 2013 - 2024)     • Infusion pumps         • Ambulatory infusion pumps         • Insulin pumps         • Syringe pumps         • Elastomeric pumps         • Patient Controlled Analgesics (PCA)     • Intravenous Sets     • IV Cannulas     • Needleless Connectors

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

[fostermarketarch]

Drug Infusion Systems Market To Hold A High Potential For Growth By 2027

The global Drug Infusion Systems market was valued at US$ xx million in the year 2019. The market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2027, with an estimated CAGR of xx% during the forecast period (2021-2027). The research study also includes exhaustive information about market dynamics such as drivers, restraints, opportunities, technological advancements, future            trends, supply chain analysis, patent landscape, pricing analysis, regulatory and reimbursement framework for precise market estimations and forecasts.

Additionally, the business intelligence study encompasses the COVID-19 scenario as follows:

·         Long-Term, Mid-Term, and Short-Term Impact of COVID-19

·         Pre- and Post-COVID-19 Scenario

·         Disruptions in the Supply Chain

Get Free PDF Brochure Of This Report @ https://www.fostermarketresearch.com/product/industry/7/376/Pdf%20Brochure/

Competitive Insights

Leading and emerging companies of the global Drug Infusion Systems market were identified based on their current offerings. Further, the Drug Infusion Systems industry is one of the most competitive industries, with the leading players actively competing against each other to gain a greater share in the industry. Some of the major companies in the Drug Infusion Systems market are: Baxter, Fresenius SE & Co. KGaA, Medtronic, Debiotech S.A., Arcomed AG, ICU Medical Inc., Braun Melsungen AG, Becton Dickinson and Company, Halyard Health Inc., Insulet Corporation, MOOG INC., IRadimed Corporation, Smiths Group Plc, Terumo Corporation, and Tandem Diabetes Care, among others

The competitive landscape of the Drug Infusion Systems industry exhibits an inclination towards emerging strategies including product launches, partnerships, collaborations and contracts, acquisitions, funding, and other developments to achieve the objectives faster.

Our reports fill up the gaps and provide you with all the detailed analysis of competitive companies involving:

·         Analyzing competitive strategies and techniques

·         Competitive positioning of key players

·         PORTER’s and SWOT analysis for competitive risk analysis

·         Competitive Share Analysis

·         Financial analysis of players to determine their withstand capacity

·         Analyzing their sales path and product study

For More Information Of This Report @ https://www.fostermarketresearch.com/product/industry/7/376/

Key Segments Covered in the global Drug Infusion Systems market report are:

·         By Product Type: Disposable Infusion System, Elastomeric Infusion System, Peristaltic Pump, Insulin Pump, Syringe Infusion System, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, and Implantable Infusion System

·         By Application: Diabetes, Nutrition, Pediatrics, Hematology, Analgesia, Oncology/Chemotherapy, and Others

·         By Route Of Administration: (Subcutaneous, Epidural, Intravenous, Arterial, and Others), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Others)

Regional Coverage:

The global Drug Infusion Systems market segregates into five regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America followed by Europe held the major share of the global market (in terms of value) in 2020. However, Asia-Pacific region exhibit highest CAGR (%) during the forecast period (2021-2027). Our research study further sub-divides regions into countries as follows:

·         North America - the U.S. and Canada

·         Europe - Germany, the U.K., France, Spain, Italy, Russia, and Rest-of-Europe

·         Asia-Pacific - China, India, Japan, South Korea, Australia, ASEAN, and Rest-of-Asia-Pacific

·         Latin America - Mexico, Brazil, and Rest-of-Latin America

·         Middle East and Africa - Gulf Cooperation Council (GCC) Countries, South Africa, Israel, and Rest-of-Middle East and Africa

Market Dynamics:

The rise in the regulatory approval for the infusion of drugs and the rise in technological advancement, especially in the countries, like the U.S., Japan, France, Italy, Germany, and others, enhance the demand for the drug infusion systems market. For instance, in January 2018, Baxter Inc. announced the gain of CE marking (a certification mark that ensures conformity with safety, health, and environmental protection standards) of the Evo IQ Infusion System and received regulatory approval by the Therapeutic Goods Administration(TGA) in Australia.

The adoption of various techniques and innovations in the healthcare industry for the better process and function of the drug infusion systems market are major factors that drive the growth of the market. For instance, in June 2020, Dr. Tracy Brown, head of life sciences at the National Engineering Laboratory, outlines the role and benefits of microfluidics in improving infusion drug techniques in the healthcare sector. The technology microfluidics enables the precise manipulation and control of fluids into an infusion of drugs and pharmaceutical fields and is expected to foster the demand for the drug infusion systems market. 

Buy Now This Business Strategic Report To Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/7/376/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane,

#1306, Dallas

Tx-75229

Phone: +1 469 4981929

Email:

support@fostermarketresearch.com

[alex121world]

Home Infusion Therapy Devices Market size Flourish at size 2028

Infusion therapy entails management of medicine through a catheter or needle. Home infusion therapy is utilized for the handling of these diseases for example diabetes, gastrointestinal diseases, cancer, acute infections cystic fibrosis and dehydration. It is permitted by physicians as well as managed by nurses and trained professionals. This therapy is utilized when the oral medication is not functional for curing of diseases.

The worldwide home infusion therapy devices market is projected to reach a market value of about US$ XX Billion by the end of the year 2018 and registering a XX% CAGR forecasted period by 2028. The growth of the overall market is mainly fuelled by rising diabetes and cancer, rising occurrences of pain, surging geriatric population, encouraging settlements for home infusion therapy in addition to increasing awareness towards the use of these devices.

However, reported errors and immeasurable product recalls, lack of trained professionals and standard usage guidelines and lack of appropriate diagnosis/treatment alternatives for the ailments are some aspects that are likely to impede the overall growth of the home infusion therapy devices market in the coming years.

Market Segmentation

On the basis of product type, the market is segmented into infusion system pumps accessories, insulin pumps, disposable elastomeric pumps and electronic ambulatory pumps and PCA pumps. Disposable elastomeric pumps will be accounting for the biggest market share by dominating the overall market and exhibiting a robust CAGR during the eight-year forecast period.

Download Research Sample with Industry Insights @ https://www.trendsmarketresearch.com/report/sample/3380

On the basis of application, the market is categorized into chemotherapy, parenteral nutrition, antibiotic administration enteral nutrition, chemotherapy, parenteral nutrition, antibiotic administration, enteral nutrition and others. The parenteral nutrition is considered to be dominating over the anticipated period along with recording a robust CAGR among other segments.

The end user market has been segmented into two broad categories long-term care centers and home care setting. The home care setting will be the most lucrative during the forecasted period, in addition, will be recording the highest CAGR in comparison to long-term care centers.

The regions are segmented on the basis of Latin America, North America, Europe, APAC and MEA. North America is likely to lead the overall market in addition to expanding at a XX% CAGR through the assessment period. However, APAC will be the fastest growing region among others in terms of revenue in the overall market by exhibiting a CAGR of XX% during the assessment period.

Key Market Players

The prominent players operating in the overall market includes • Baxter International Inc. • Johnson & Johnson Private Limited (Animas Corporation) • Becton, Dickinson and Company • B. Braun Melsungen AG. • Pfizer Inc. • Terumo Corporation • Fresenius Kabi AG • Smith & Nephew • F. Hoffmann-La Roche AG • Micrel Medical Devices S.A.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.trendsmarketresearch.com/report/requesttoc/3380

[sapanas]

Closed System Drug Transfer Device (CSTD) Market Global Projection And Developments Status

Closed System Drug Transfer Device (CSTD) Market Insight

The closed system drug transfer device (CSTD) market is growing rapidly over recent years. Factors such as the rising prevalence of cancer and the need to protect healthcare workers and biotechnology scientists & assistants against the harmful risks of hazardous drug exposure are driving the growth of the market. Besides, guidelines outlined by federal agencies such as the National Institute for Occupational Safety and Health (NIOSH) to prevent possible workplace hazards are spurring the CSTD market demand.

Moreover, rapid advancements in medical science & biotechnology and increasing adoption of the latest technologies are accelerating the growth of the market. Market Research Future (MRFR) states that the global closed system drug transfer device (CSTD) market is expected to reach a valuation of USD 6,312.52 MN by 2025. In its latest report, MRFR also asserts that the market would register a CAGR of 19.10% throughout the forecast period (2018-2025). Rising cancer cases is a primary growth driver.

Furthermore, the growing uses of biologics and substantial investments drawn in the R&D to develop advanced CSTDs are boosting the growth of the market significantly. Additionally, spreading awareness, advantages of CSTD, and beneficial reimbursement policies impact the market growth, positively.

USP General Chapter <800>, published on February 1, 2016, with an implementation date of December 2019 describing the practice and quality standards for handling hazardous drugs in health care settings will significantly impact healthcare institutions. With USP <800> implementation date proceeding rapidly, pre-planning for compliance is becomes paramount. For the required coordination and efficiency for implementation of USP <800>, CSTD manufacturers have created online resources to help healthcare providers with the preparation.

These documentations provide valuable insights, interactive resources, and a detailed requirement checklist for HC institutions that want to start on planning and implementing the new protocols. They strive to develop USP <800> complied CSTDs to help healthcare facilities to prevent accidental exposure to hazardous drugs for workers and patients during compounding and administration.

Closed System Drug Transfer Device (CSTD) Market – Segments

The market is segmented into four dynamics to widen the scope of understanding,

By Type         : Barrier-Type and Filtration-Type.

By Delivery : Closed Vial Access Devices, Closed Bag/Line Access Devices, and Closed Syringe Safety Devices.

By End-user : Specialty Centers, Hospitals & Clinics, and others.

By Regions  : Europe, North America, APAC, and the Rest-of-the-World (RoW).

Closed System Drug Transfer Device (CSTD) Market – Geographical Analysis

North America dominates the global closed system drug transfer device market with the largest market share. Major factors that are driving the regional market growth include the rise in cancer cases and funding support to encourage research and development infrastructure. Additionally, well-spread awareness of CSTD alongside technological advances in the healthcare industry boosts the growth of the regional market.

A huge patient pool undergoing treatments for cancer and the increasing geriatric population in the region support the growth of the market. Moreover, surging numbers of research activities and comparatively higher adoption of related CSTDs in the US and Canada impact the regional market growth, positively. Furthermore, the presence of major market players and developed healthcare infrastructure foster regional market growth.

Europe is another phenomenally growing market closed system drug transfer device, globally. Flourishing medical device markets, burgeoning life science industries, and the presence of pharma giant companies bolster the regional market growth.

The resurging economy in Europe plays a vital role in market development, allowing the proliferation of the healthcare sector in the region. Furthermore, increasing investment in the development of CSTDs drives the regional market on a large scale. The European CSTD market is estimated to register a phenomenal CAGR during the review period.

Closed System Drug Transfer Device market in the Asia Pacific region is growing rapidly. This growth attributes to the investments by new players and the increasing prevalence of cancer. Besides, government initiatives to encourage safe drug handling practices in India and China are influencing regional market growth. Furthermore, the growing demand for quality devices in biotechnology and rapidly developing healthcare technology is expected to lead the market growth in the APAC region.

Closed System Drug Transfer Device (CSTD) Market – Competitive Landscape

The closed CSTD market appears to be fiercely competitive and fragmented due to the presence of many well-established players. To garner a more significant share in the market, brand reinforcement, mergers & acquisitions, and innovation remain the popular trends for the key players.

Closed System Drug Transfer Device (CSTD) Market Major Players:

Players leading the CSTD market include Teva Pharmaceutical Industries Ltd. (Israel), Becton, Dickinson and Company (US), Equashield LLC (US), Yukon Medical (US), ICU Medical Inc. (US), and Corvida Medical (US), among others.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/closed-system-drug-transfer-device-market-7733

Closed System Drug Transfer Device (CSTD) Industry/ Innovation/ Related News:

March 09, 2019 ---- B. Braun Medical Inc. (the US), a leading global provider of innovative medical products, showcased its extensive portfolio of products, services, and technology at National Home Infusion Association (NHIA) Conference & Exposition 2019, held at the Gaylord Palms Convention Center in Orlando, during March 9-13.

The major product featured by B. Braun was a Closed System Transfer Device (CSTD) - OnGuard®, which is the market leader in CSTD air-cleaning technology. OnGuard protects healthcare workers and others against the harmful risks of hazardous drug exposure. The special features of this technology are designed to make OnGuard easy to operate and integrate into practice. Other featured products and services included APEX® Compounding System, Easypump® ST/LT Elastomeric Infusion Pump, CAPS® Services, and CAPS Consulting, among several others.